+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Patient Recruitment and Retention Services Market, 2019-2030

  • ID: 4764178
  • Report
  • Region: Global
  • 300 Pages
  • Roots Analysis
1 of 4

FEATURED COMPANIES

  • Abnex
  • Box
  • Clinverse
  • Gitzo Pharmaceuticals
  • Mundipharma Research
  • Rep Network
  • MORE

Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose immense financial pressure on sponsors. Amongst several known challenges, patient recruitment is considered to be one of the rate-limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don’t even enroll a single patient. In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit/retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.

The abovementioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research. Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs / personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future. In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.

The ‘Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient recruitment (including pre-screening and Institutional Review Board (IRB) / Ethics Committee (EC) submission), [B] patient retention (considering various strategies, such as the use of study-branded gifts, study-branded reminders, providing education and support materials, reimbursement programs, transportation programs, patient engagement web site, patient reconnect programs, mobile applications to track patient engagement and others) and [C] other associated services (including site identification and selection,study feasibility / protocol development, project management, clinical trial monitoring and other services), year of establishment, geographical location, and size of company. The chapter also covers an analysis of the geographical reach and therapeutic expertise of service providers, along with details on the payment model, patient recruitment platforms/technologies used, and the various certifications/accreditations awarded by regulatory bodies.
  • An analysis of the most active regions (in terms of patient recruitment activity), based on the locations of headquarters of companies engaged in this domain, featuring schematic world map representations that highlight key hubs across the globe.
  • An insightful 2X2 representation of the results of a competitiveness analysis of various service providers (segregated into three peer groups based on their employee count (small-sized (1-50 employees), mid-sized (50-200 employees) and large (>200 employees)), highlighting capable players in this domain, based on their respective capabilities.
  • Comprehensive profiles of patient recruitment and retention service providers, featuring information on the location of their headquarters, year of establishment, patient recruitment services/platforms portfolio, recent developments, and a comprehensive future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering outsourcing agreements, service alliances, acquisitions, joint ventures, mergers, technology licensing and development agreements, and other forms of partnerships.
  • A review of emerging trends in the industry, including the use of social media, mobile technologies, EHRs and RWE, to overcome the challenges associated with patient recruitment and retention.

One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030. In addition, we have segmented the future opportunity across [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others), [B] steps in patient recruitment process (pre-screening and screening), [C] phases of development (phase I, phase II, phase III and phase IV), and [D] different global regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):

  • Simon Klaasen (Co-founder and Managing Director, Link2Trials)
  • Hagit Nof (Chief Operation Officer and Business Development, nRollmed)
  • Paul Ivsin (Managing Director, Seeker Health)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD unless otherwise specified.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abnex
  • Box
  • Clinverse
  • Gitzo Pharmaceuticals
  • Mundipharma Research
  • Rep Network
  • MORE

1. Preface
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
  
2. Executive Summary

3. Patient Recruitment And Retention In Clinical Trials
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services
  
4. Patient Outreach Methods
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio 
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach
  
5. Competitive Market Landscape Of Patient Recruitment And Retention Service Providers
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
  
6. Company Competitiveness Analysis
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies
  
7. Company Profiles
7.1. Chapter Overview
7.2. Patient Recruitment Service Providers in North America
7.2.1. Acurian 
7.2.1.1. Company Overview
7.2.1.2. Financial Information
7.2.1.3. Patient Recruitment and Retention Services
7.2.1.4. Recent Developments
7.2.1.5. Future Outlook
7.2.2. BBK Worldwide
7.2.2.1. Company Overview
7.2.2.2. Financial Information
7.2.2.3. Patient Recruitment and Retention Services
7.2.2.4. Recent Developments
7.2.2.5. Future Outlook
7.2.3. Bright Pharmaceuticals Services
7.2.3.1. Company Overview
7.2.3.2. Patient Recruitment and Retention Services
7.2.3.3. Future Outlook
7.2.4. ClinEdge 
7.2.4.1. Company Overview
7.2.4.2. Patient Recruitment and Retention Services
7.2.4.3. Recent Developments
7.2.4.4. Future Outlook
7.2.5. CSSi 
7.2.5.1. Company Overview
7.2.5.2. Patient Recruitment and Retention Services
7.2.5.3. Recent Developments
7.2.5.4. Future Outlook
7.2.6. CTM 
7.2.6.1. Company Overview
7.2.6.2. Patient Recruitment and Retention Services
7.2.6.2 Future Outlook
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.7.1. Company Overview
7.2.7.2. Patient Recruitment and Retention Services
7.2.7.3. Recent Developments
7.2.7.4. Future Outlook
7.2.8. MMG 
7.2.8.1. Company Overview
7.2.8.2. Patient Recruitment and Retention Services
7.2.8.3. Future Outlook
7.2.9. Topstone Research
7.2.9.1. Company Overview
7.2.9.2. Patient Recruitment and Retention Services
7.2.9.3. Future Outlook
7.2.10. WCCT Global
7.2.10.1. Company Overview
7.2.10.2. Financial Information
7.2.10.3. Patient Recruitment Services
7.2.10.4. Recent Developments
7.2.10.5. Future Outlook
7.3. Patient Recruitment Service Providers in Europe
7.3.1. Antidote 
7.3.1.1. Company Overview
7.3.1.2. Financial Information
7.3.1.3. Patient Recruitment and Retention Services
7.3.1.4. Recent Developments
7.3.1.5. Future Outlook
7.3.2. Fidelis Research
7.3.2.1. Company Overview
7.3.2.2. Financial Information
7.3.2.3. Patient Recruitment and Retention Services
7.3.2.4. Recent Developments
7.3.2.5. Future Outlook
7.3.3. Ignite Data
7.3.3.1. Company Overview
7.3.3.2. Financial Information
7.3.3.3. Patient Recruitment and Retention Services
7.3.3.4. Future Outlook
7.3.4. Polaris BioPharma Consulting
7.3.4.1. Company Overview
7.3.4.2. Patient Recruitment and Retention Services
7.3.4.3. Recent Developments
7.3.5. Tudor Reilly Health
7.3.5.1. Company Overview
7.3.5.2. Financial Information
7.3.5.3. Patient Recruitment and Retention Services
7.3.5.4. Recent Developments
7.3.5.5. Future Outlook
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROèe 
7.4.1.1. Company Overview
7.4.1.2. Patient Recruitment and Retention Services
7.4.1.3. Recent Developments
7.4.1.4. Future Outlook
7.4.2. Jsure Healthmedia
7.4.2.1. Company Overview
7.4.2.2. Patient Recruitment and Retention Services
7.4.2.3. Future Outlook
7.4.3. TrialWire 
7.4.3.1. Company Overview
7.4.3.2. Patient Recruitment and Retention Services
7.4.3.3. Recent Developments
7.4.4. Pacific Groove
7.4.4.1. Company Overview
7.4.4.2. Patient Recruitment and Retention Services
7.4.4.3. Recent Developments
7.4.4.4. Future Outlook
  
8. Partnerships And Collaborations
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements
  
9. Recent Trends In Patient Recruitment And Retention
9.1. Chapter Overview
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets
  
10. Future Growth Opportunities
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing
  
11. Market Sizing And Opportunity Analysis
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.2.1. Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030
11.7.2.2. Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030
11.7.2.3. Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030
11.7.2.4. Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.3.1. Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030
11.7.3.2. Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030
11.7.3.3. Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030
11.7.3.4. Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030
11.7.3.5. Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030
11.7.3.6. Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030
11.7.3.7. Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030
11.7.3.8. Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030
11.7.3.9. Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030
11.7.3.10. Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.4.1. Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030
11.7.4.2. Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030
11.7.4.3. Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030
11.7.4.4. Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030
11.7.4.5. Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030
11.7.4.6. Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030
11.7.4.7. Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030
11.7.4.8. Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030
11.7.4.9. Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030
11.7.4.10. Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
11.7.5.1. Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030
11.7.5.2. Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030
  
12. Conclusion
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade
  
13. Interview Transcripts 
13.1. Chapter Overview   
13.2. Link2Trials
13.2.1. Interview Transcript: Simon Klaasen, Co-founder and Managing Director
13.3. nRollmed 
13.3.1. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer
13.4. Seeker Health
13.4.1. Interview Transcript: Paul Ivsin, Managing Director
  
14. Appendix 1: Tabulated Data
  
15. Appendix 2: List Of Companies And Organizations

List of Figures
Figure 3.1 Factors Contributing to Clinical Trial Costs
Figure 3.2 The Patient Recruitment Process
Figure 3.3 Factors Influencing Participation in Clinical Trials
Figure 3.4 Reasons for Patient Dropouts from Clinical Studies
Figure 4.1 Patient Recruitment: Advantages and Limitations of Traditional Media
Figure 4.2 Patient Recruitment: Advantages and Limitations of Social Media
Figure 5.1 Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment          
Figure 5.2 Patient Recruitment and Retention Service Providers: Distribution by Company Size       
Figure 5.3 Patient Recruitment and Retention Service Providers: Distribution by Geography
Figure 5.4 Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size
Figure 5.5 Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
Figure 5.6 Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods        
Figure 5.7 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
Figure 5.8 Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services 
Figure 5.9 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered    
Figure 5.10 Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods        
Figure 5.11 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods    
Figure 5.12 Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach          
Figure 5.13 Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise          
Figure 6.1 Company Competitiveness Analysis: Small-Sized Players
Figure 6.2 Company Competitiveness Analysis: Mid-Sized Players
Figure 6.3 Company Competitiveness Analysis: Large Players
Figure 7.1 Acurian: Innovative Tools / Approaches for Patient Recruitment
Figure 7.2 Acurian: Patient Recruitment Solutions and Strategies
Figure 7.3 BBK Worldwide: Service Portfolio
Figure 7.4 Bright Pharmaceutical Services: Service Portfolio
Figure 7.5 ClinEdge: Service Portfolio
Figure 7.6 CSSi: Patient Recruitment and Retention Capabilities
Figure 7.7 CSSi: Patient Recruitment Strategies
Figure 7.8 CTM: Patient Recruitment Process
Figure 7.9 CTM: Outreach Methods Used to Recruit Patients
Figure 7.10 CTM: Technologies Used to Recruit Patients
Figure 7.11 Topstone Research: Service Portfolio
Figure 7.12 Antidote: Services Portfolio
Figure 7.13 Antidote Base: Patient Recruitment Process
Figure 7.14 Fidelis Research: Service Portfolio
Figure 7.15 Ignite Data: Patient Recruitment and Call-Screening Process
Figure 7.16 Ignite Data: Patient Recruitment and Retention Strategies
Figure 7.17 Ignite Data: Real-World Data Delivery Process
Figure 7.18 Polaris Biopharma Consulting: Core Capabilities
Figure 7.19 Polaris Biopharma Consulting: Service Portfolio
Figure 7.20 Tudor Reilly Health: Service Portfolio
Figure 7.21 Tudor Reilly Health: Local Support Divisions
Figure 7.22 CROèe: Service Portfolio
Figure 7.23 TrialWire: Patient Recruitment Process
Figure 7.24 TrialWire: The RapidRecruit Platform
Figure 7.25 Pacific Groove: Business Divisions
Figure 7.26 Pacific Groove: Patient Enrollment Process
Figure 8.1 Partnerships and Collaborations: Distribution by Year, 2013-2018
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Purpose of Agreement
Figure 8.4 Partnerships and Collaborations: Analysis by Therapeutic Area
Figure 8.5 Partnerships and Collaborations: Most Active Players
Figure 8.6 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 9.1 Recent Trends in Patient Recruitment and Retention
Figure 10.1 Patient Recruitment Services Market: Future Growth Opportunities
Figure 10.2 Number of Global Clinical Trials Registered by Year, 2000-2018
Figure 10.3 Evolution of Clinical Trial Regulations in the US
Figure 11.1 Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)
Figure 11.2 Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%) 
Figure 11.3 Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
Figure 11.4 Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.5 Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
Figure 11.6 Patient Recruitment Services Market: Market Attractiveness Analysis by Country
Figure 11.7 Patient Recruitment Services Market in North America, 2019-2030 (USD Billion)
Figure 11.8 Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.9 Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.10 Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.11 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.12 Patient Recruitment Services Market in EU5, 2019-2030 (USD Billion)
Figure 11.13 Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.14 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.15 Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.16 Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.17 Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.18 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.19 Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.20 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.21 Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.22 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.23 Patient Recruitment Services Market in Asia Pacific, 2019-2030 (USD Billion)
Figure 11.24 Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.25 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.26 Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.27 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.28 Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.29 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.30 Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.31 Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.32 Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.33 Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.34 Patient Recruitment Services Market in Rest of the World, 2019-2030 (USD Billion)
Figure 11.35 Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.36 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 12.1 Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

List of Tables
Table 3.1 Salient Features of Clinical Trial Phases
Table 4.1 Traditional and Emerging Patient Outreach Methods
Table 5.1 List of Patient Recruitment and Retention Service Providers
Table 5.2 Patient Recruitment and Retention Service Providers: Information on Patient Outreach Methods
Table 5.3 Patient Recruitment and Retention Service Providers: Information on Type of Patient Recruitment Services
Table 5.4 Patient Recruitment and Retention Service Providers: Information on Patient Retention Methods
Table 5.5 Patient Recruitment and Retention Service Providers: Information on Geographical Reach
Table 5.6 Patient Recruitment and Retention Service Providers: Information on Therapeutic Expertise
Table 5.7 Patient Recruitment and Retention Service Providers: Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
Table 7.1 Acurian: Funding
Table 7.2 Acurian: Future Outlook
Table 7.3 BBK Worldwide: Future Outlook
Table 7.4 ClinEdge: Future Outlook
Table 7.5 CSSi: Future Outlook
Table 7.6 WCCT Global: Future Outlook
Table 7.7 Antidote: Funding
Table 7.8 Antidote: Future Outlook
Table 7.9 Ignite Data: Future Outlook
Table 7.10 Tudor Reilly Health: Future Outlook
Table 7.11 CROèe: Future Outlook
Table 7.12 Pacific Groove: Future Outlook
Table 8.1 Patient Recruitment and Retention Services: Partnerships and Collaborations, 2013-2018
Table 14.1 Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment   
Table 14.2 Patient Recruitment and Retention Service Providers: Distribution by Company Size   
Table 14.3 Patient Recruitment and Retention Service Providers: Distribution by Geography   
Table 14.4 Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size   
Table 14.5 Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
Table 14.6 Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods   
Table 14.7 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
Table 14.8 Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services   
Table 14.9 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered   
Table 14.10 Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods   
Table 14.11 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods    
Table 14.12 Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach   
Table 14.13 Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise   
Table 14.14 Company Competitiveness Analysis: Small-Sized Players
Table 14.15 Company Competitiveness Analysis: Mid-Sized Players
Table 14.16 Company Competitiveness Analysis: Large Players
Table 14.17 Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)
Table 14.18 Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%)
Table 14.19 Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
Table 14.20 Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.21 Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
Table 14.22 Patient Recruitment Services Market: Market Attractiveness Analysis by Country
Table 14.23 Patient Recruitment Services Market in North America, 2019-2030 (USD Billion)
Table 14.24 Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.25 Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.26 Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.27 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.28 Patient Recruitment Services Market in EU5, 2019-2030 (USD Billion)
Table 14.29 Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.30 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.31 Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.32 Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.33 Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.34 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.35 Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.36 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.37 Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.38 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.39 Patient Recruitment Services Market in Asia Pacific, 2019-2030 (USD Billion)
Table 14.40 Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.41 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.42 Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.43 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.44 Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.45 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.46 Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.47 Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.48 Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.49 Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.50 Patient Recruitment Services Market in Rest of the World, 2019-2030 (USD Billion)
Table 14.51 Phases of Development, 2019-2030 (USD Billion)
Table 14.52 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.53 Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abnex
  • Box
  • Clinverse
  • Gitzo Pharmaceuticals
  • Mundipharma Research
  • Rep Network
  • MORE

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the current state of the patient recruitment and retention services market and describes the upcoming opportunity in short to mid-term and long term.

Chapter 3 provides a general introduction to the patient recruitment and retention process in clinical trials. It includes a detailed discussion on the different phases of clinical trials, patient recruitment and its associated challenges, various strategies used to enhance patient accrual, affiliated ethical considerations and outsourcing activity in this domain. Further, it includes a detailed discussion on the various patient recruitment services offered by different contract service providers. Additionally, the chapter features a discussion on diverse patient retention strategies that are presently being employed to prevent enrolled participants from dropping out of clinical research studies.

Chapter 4 provides a comprehensive overview of the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials. The chapter also highlights the various advantages and limitations of these outreach methods.

Chapter 5 provides a comprehensive view of the current market landscape of companies that offer patient recruitment and retention services. It presents detailed analyses on the basis of their year of establishment, geographical location, size of company, type of services offered, type of patient outreach methods, geographical reach, and the therapeutic expertise of service providers. In addition, it includes details on the payment model, patient recruitment platforms / technologies used, and the various certifications / accreditations awarded to companies, by regulatory bodies from across the world.

Chapter 6 features a competitiveness analysis of the companies providing patient recruitment and retention services based on various parameters, such as patient outreach methods, number of patient recruitment and retention services offered, therapeutic expertise, geographical reach and year of establishment. In the chapter, stakeholder entities have been plotted on a 2X2 matrix, having a company’s Experience (based on its year of establishment)(abscissa) and Company Competitiveness (ordinate) as the two axes.

Chapter 7 features detailed profiles of key stakeholders in this industry; each profile provides information on their headquarters, year of establishment, patient recruitment services / platforms portfolio, recent developments and a comprehensive future outlook.

Chapter 8 features an elaborate discussion and analysis of the various partnerships / collaborations that have been inked amongst players in this market. It includes a brief description on the various types of partnership models (outsourcing agreements, service alliances, acquisitions, joint ventures, mergers, technology licensing agreements, development agreements, and others) adopted by industry stakeholders, highlighting the most common forms of deals / agreements that have been established in the period between 2013-2018.

Chapter 9 provides a detailed overview of the prevalent trends in the patient recruitment and retention services domain, including the use of social media, mobile technologies, EHRs and RWE, to overcome the challenges associated with patient recruitment and retention in clinical research.

Chapter 10 features a detailed discussion on the upcoming opportunities (such as rise in the number of clinical trials, development of personalized medicine / orphan drugs, growing opportunities in emerging markets, increasing preference for one-stop solutions and others) in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.

Chapter 11 features a comprehensive market forecast analysis, highlighting the future potential of patient recruitment services market till the year 2030. We have segmented the projected opportunity on the basis of [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others), [B] steps in patient recruitment process (pre-screening and screening), [C] phases of development (phase I, phase II, phase III and phase IV), and [D] different global regions (North America, Europe, Asia-Pacific and rest of the world).

Chapter 12 summarizes the entire report. It presents a list of key takeaways from the report, and offers our independent opinion on the current market scenario.

Chapter 13 is a collection of interview transcripts of the discussions that were held with key stakeholders in this market. The chapter provides details of interviews held with Simon Klaasen (Co-founder and Managing Director, Link2Trials), Hagit Nof (Chief Operation Officer and Business Development, nRollmed) and Paul Ivsin (Managing Director, Seeker Health).

Chapter 14 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 15 is an appendix, which provides the list of companies and organizations mentioned in the report.

Note: Product cover images may vary from those shown
5 of 4
  • Abnex
  • Access Clinical Research
  • Accurate Clinical Research
  • Acurian
  • AD VERBUM
  • Advanced Clinical
  • Affordable Clinical Trials Outsourcing
  • Akcelis
  • Alleco Trials
  • Alliance for Clinical Research Excellence and Safety
  • Allscripts
  • American Liver Foundation
  • American Society of Clinical Oncology
  • Amgen
  • Antidote
  • ApotheCom
  • Apparelyzed
  • Apptomics
  • AQLANE Medical
  • Arden and Schmidt
  • AstraZeneca
  • ATLAS Medical Services
  • AutoCruitment
  • AXELLE Group
  • Axiom Marketing
  • BBK Worldwide
  • BDD
  • BIAPharm
  • Bio-Optronics
  • Bioclinica
  • BioScript
  • Bladder & Bowel Community
  • Blueprint Clinical
  • BlueTheory Clinical Trials
  • BMC Group
  • Box
  • Bridge Clinical Research
  • Bright Pharmaceutical Services
  • Buzzreach
  • C&C Clinical Laboratory Consulting
  • Canadian Institute for Medical Advancement
  • Capsule Communications
  • CaringKind
  • CarthagoPharma
  • Center Point Clinical Services
  • Centricity Health
  • Chandler Chicco Agency
  • Chase Medical Research
  • Cinven
  • Circuit Clinical
  • Clariness
  • Clear Clinica
  • Clinart MENA
  • ClinEdge
  • Clinerion
  • Clinical Ambassador
  • Clinical List America
  • Clinical Trial
  • Clinical Trial Connect
  • Clinical Trial Marketing Communications
  • Clinical Trial Networking
  • Clinical Trials Center
  • Clinical Trials Group
  • ClinicalConnection
  • Clinically Media
  • ClinIntel
  • CliniSpan Health
  • Clinspire Research
  • Clintec
  • Clintract
  • Clinverse
  • CMX Research
  • Compass Research
  • Continuum Clinical
  • CPS Research
  • CROee
  • CSSi
  • CTM
  • Cyclone
  • Cytespace
  • DAC Patient Recruitment Services
  • DAVA Oncology
  • DrFirst
  • Eastern Medical
  • Effectus CTR
  • EGeen
  • Elligo Health Research
  • EmergingMed
  • eNre
  • ePatientFinder
  • eStudySite
  • Euclid SR Partners
  • European Organization for Research and Treatment of Cancer
  • EVERSANA
  • FDAMap
  • Fidelis Research
  • Flatiron Health
  • Foundation for the National Institutes of Health
  • Foundation Medicine
  • Friends of Cancer Research
  • Gaea Clinical
  • Galen Patient Recruitment
  • GCP Clinical Studies
  • Genentech
  • Gitzo Pharmaceuticals
  • Global Clinical Trials
  • Global Perspectives
  • GuideStar Research
  • Heron Therapeutics
  • Ignite Data
  • IMS Health
  • Incontinence UK
  • Innovative Trials
  • INSPIRE
  • Institute of Clinical Research India
  • Integrated Clinical Trial Services
  • IQVIA
  • IRM
  • J Trotter Research & Consulting
  • JLL Partners
  • JP Morgan Partners
  • KCR
  • Klick Health
  • Langland
  • LeadSlinger
  • Linical Accelovance
  • Link2Trials
  • Live Doctors
  • LongTaal
  • Lyft
  • Lymphoma Action
  • Medical Research South
  • MediciGroup
  • Melanoma Research Alliance
  • Merck Capital Ventures
  • Miami Research Associates
  • MMG
  • Mondosano
  • Mundipharma Research
  • National Cancer Institute
  • Northumbria Healthcare NHS Foundation Trust
  • nRollmed
  • O4 Research
  • One Research
  • orphan reach
  • Orphanos
  • Osaka International Cancer Institute
  • Pacific Grove
  • Parallel 6
  • PAREXEL
  • Patient Enrollment Advisors
  • Patient RM
  • PatientEvolution
  • Patients Direct
  • PatientWise
  • Patiro
  • Pepgra
  • Pfizer
  • Pharm-Olam
  • PharmaCentra
  • Pharmaceutical Product Development
  • phaware global association
  • Physicians Plasma Alliance
  • Polaris Biopharma Consulting
  • PPH plus
  • Practice Fusion
  • Praxis Communications
  • PRC Clinical
  • Profil
  • ProQuest Investments
  • Publicis Healthcare Communications Group
  • PWNHealth
  • QPS
  • Radiant Research
  • RealTime Software Solutions
  • RemediumOne
  • Remedy Health Media
  • Rep Network
  • RESolutions
  • Roche
  • S4 Research
  • Seeker Health
  • Sinque Labs
  • SitePartner
  • SMO Clinical Research
  • SMO ClinPlus
  • Society for Clinical Research Sites
  • Spectrum Clinical Research
  • Spinal Cord Injury Network
  • Splash Clinical
  • SubjectWell
  • SWOG Cancer Research
  • Syneos Health
  • Synexus
  • TFS
  • The Academic Network
  • The Patient Experience Project
  • The Patient Recruiting Agency
  • The Patient Recruitment Consultancy
  • ThreeWire
  • Topstone Research
  • Total Clinical Trial Management
  • Trial Connections
  • Trialfacts
  • TrialJoin
  • TrialSpark
  • TrialWire
  • Tudor Reilly Health
  • United BioSource
  • University of Exeter
  • University of Glasgow
  • University of Strathclyde
  • Veristat
  • Viomedo
  • VisibilityRx
  • Vizae Clinical Trial Management
  • WCCT Global
  • WIRB-Copernicus Group
  • Worldwide Clinical Trials
  • X Factor Advertising
Note: Product cover images may vary from those shown
Adroll
adroll